Cite

MLA Citation

    A Vidal-Jordana et al.. “Significant clinical worsening after natalizumab withdrawal: Predictive factors.” Multiple sclerosis, vol. 21, 2015, pp. 780–785. http://access.bl.uk/ark:/81055/vdc_100060406822.0x000006
  
Back to record